Mirum Pharmaceuticals, Inc. (MIRM)
82.93
-0.99
(-1.18%)
USD |
NASDAQ |
Oct 02, 16:00
81.77
-1.16
(-1.40%)
After-Hours: 20:00
Mirum Pharmaceuticals Market Cap : 5.370B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 5.370B |
| October 01, 2026 | 5.434B |
| September 30, 2026 | 5.535B |
| September 29, 2026 | 5.669B |
| September 28, 2026 | 5.696B |
| September 25, 2026 | 5.808B |
| September 24, 2026 | 5.786B |
| September 23, 2026 | 5.784B |
| September 22, 2026 | 5.918B |
| September 21, 2026 | 5.957B |
| September 18, 2026 | 5.946B |
| September 17, 2026 | 6.399B |
| September 16, 2026 | 6.305B |
| September 15, 2026 | 6.080B |
| September 14, 2026 | 6.265B |
| September 11, 2026 | 6.360B |
| September 10, 2026 | 6.515B |
| September 09, 2026 | 6.365B |
| September 08, 2026 | 6.445B |
| September 04, 2026 | 6.534B |
| September 03, 2026 | 6.516B |
| September 02, 2026 | 6.464B |
| September 01, 2026 | 6.368B |
| August 31, 2026 | 6.349B |
| August 28, 2026 | 6.311B |
| Date | Value |
|---|---|
| August 27, 2026 | 6.459B |
| August 26, 2026 | 6.379B |
| August 25, 2026 | 6.351B |
| August 24, 2026 | 6.263B |
| August 21, 2026 | 6.237B |
| August 20, 2026 | 6.286B |
| August 19, 2026 | 6.621B |
| August 18, 2026 | 6.532B |
| August 17, 2026 | 6.464B |
| August 14, 2026 | 6.517B |
| August 13, 2026 | 6.396B |
| August 12, 2026 | 6.409B |
| August 11, 2026 | 6.361B |
| August 10, 2026 | 6.391B |
| August 07, 2026 | 6.518B |
| August 06, 2026 | 6.094B |
| August 05, 2026 | 6.850B |
| August 04, 2026 | 6.756B |
| August 03, 2026 | 6.372B |
| July 31, 2026 | 6.455B |
| July 30, 2026 | 6.860B |
| July 29, 2026 | 6.554B |
| July 28, 2026 | 6.838B |
| July 27, 2026 | 6.958B |
| July 24, 2026 | 6.886B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 23.17B |
| Insmed, Inc. | 24.26B |
| Galectin Therapeutics, Inc. | 258.62M |
| Kodiak Sciences, Inc. | 5.934B |
| Praxis Precision Medicines, Inc. | 8.250B |
Market Cap Related Metrics
| PS Ratio | 7.743 |
| PEG Ratio | -0.0052 |
| Price | 82.93 |
| Earnings Yield | -17.54% |
| PEGY Ratio | -0.0052 |